We are live on ! Find out more
HCM

Hillman Capital Management Portfolio holdings

AUM $144M
1-Year Est. Return 7.02%
This Fund
S&P 500
This Quarter Est. Return
+12.32%
1 Year Est. Return
+7.02%
3 Year Est. Return
+20.27%
5 Year Est. Return
+21.27%
10 Year Est. Return
AUM
$255M
AUM Growth
+$13.6M
Cap. Flow
-$10.8M
Cap. Flow %
-4.23%
Top 10 Hldgs %
34.5%
Holding
53
New
5
Increased
4
Reduced
43
Closed
1

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.75M
2
ASML icon
ASML
ASML
+$1.66M
3
CAG icon
Conagra Brands
CAG
+$1.54M
4
DD icon
DuPont de Nemours
DD
+$1.38M
5
T icon
AT&T
T
+$1.28M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Healthcare 15.51%
3 Communication Services 14.31%
4 Consumer Staples 13.11%
5 Financials 10.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BUD icon
1
AB InBev
BUD
$156B
$9.24M 3.63%
153,961
-6,246
-4% -$335K
WFC icon
2
Wells Fargo
WFC
$269B
$9.11M 3.58%
220,580
-6,642
-3% -$294K
KHC icon
3
Kraft Heinz
KHC
$29B
$9.09M 3.57%
223,350
-7,303
-3% -$277K
BA icon
4
Boeing
BA
$183B
$9.08M 3.57%
47,676
-2,118
-4% -$346K
CVS icon
5
CVS Health
CVS
$121B
$8.91M 3.5%
95,635
-707
-0.7% -$68.2K
SPG icon
6
Simon Property Group
SPG
$71.1B
$8.69M 3.41%
73,961
-2,276
-3% -$253K
MSFT icon
7
Microsoft
MSFT
$3.66T
$8.52M 3.35%
35,544
-926
-3% -$222K
K
8
DELISTED
Kellanova
K
$8.46M 3.32%
126,437
-1,132
-0.9% -$76.8K
GSK icon
9
GSK
GSK
$101B
$8.36M 3.28%
237,879
-6,099
-2% -$203K
BIIB icon
10
Biogen
BIIB
$30.8B
$8.33M 3.27%
30,076
-1,678
-5% -$474K
EPD icon
11
Enterprise Products Partners
EPD
$81.9B
$8.27M 3.25%
342,945
-2,845
-0.8% -$70K
T icon
12
AT&T
T
$167B
$8.02M 3.15%
435,411
-71,271
-14% -$1.28M
DD icon
13
DuPont de Nemours
DD
$19.5B
$7.98M 3.14%
92,671
-17,283
-16% -$1.38M
TSM icon
14
TSMC
TSM
$2.24T
$7.44M 2.92%
99,850
-2,486
-2% -$180K
ASML icon
15
ASML
ASML
$699B
$7.13M 2.8%
13,047
-3,172
-20% -$1.66M
EMR icon
16
Emerson Electric
EMR
$91.8B
$6.96M 2.73%
72,420
-668
-0.9% -$60K
BNY
17
Bank of New York Mellon
BNY
$110B
$6.95M 2.73%
152,779
-1,306
-0.8% -$56K
CMP icon
18
Compass Minerals
CMP
$1.11B
$6.76M 2.66%
164,812
-5,948
-3% -$246K
WBD icon
19
Warner Bros
WBD
$69B
$6.72M 2.64%
709,126
+161,793
+30% +$1.83M
BDX icon
20
Becton Dickinson
BDX
$49.8B
$6.7M 2.63%
26,335
-761
-3% -$180K
ZBH icon
21
Zimmer Biomet
ZBH
$18.4B
$6.2M 2.43%
48,596
-10,302
-17% -$1.2M
RTX icon
22
RTX Corp
RTX
$300B
$6.14M 2.41%
60,795
-11,749
-16% -$1.11M
CAG icon
23
Conagra Brands
CAG
$7.19B
$6.04M 2.37%
156,148
-42,441
-21% -$1.54M
INTC icon
24
Intel
INTC
$516B
$5.98M 2.35%
226,245
-17,194
-7% -$478K
LRCX icon
25
Lam Research
LRCX
$409B
$5.83M 2.29%
138,680
-4,820
-3% -$202K

Similar funds

Hillman Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hillman Capital Management held 53 positions worth $255M, up 5.7% from $241M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Hillman Capital Management withdrew a net $10.8M in Q4 2022, closing 1 position and reducing 43 holdings. Its most notable exit was Merck, an estimated $5.75M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Hillman Capital Management opened a new position in Walt Disney worth $5.71M.

  • Hillman Capital Management's largest Q4 2022 buy was Walt Disney: 65,744 shares worth $5.71M.
  • Hillman Capital Management added most to Warner Bros in Q4 2022, an estimated $1.83M increase.
  • Hillman Capital Management's biggest Q4 2022 reduction was ASML, cutting an estimated $1.66M.
  • Hillman Capital Management fully exited Merck in Q4 2022, selling an estimated $5.75M.
  • Hillman Capital Management's ten largest holdings make up 34% of its $255M portfolio in Q4 2022.
  • Hillman Capital Management opened 5 new positions and closed 1 in Q4 2022.
  • Hillman Capital Management's portfolio value rose 5.7% quarter-over-quarter to $255M.

Based on Hillman Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.